#Coronavirus Disease Research #References (AMEDEO, May 16 '26)

 

Ann Intern Med

1. JOHNSON D, Quinn S, Algase LF, Watkins C Jr, et al
   Telemedicine Policy and Practice: A Position Paper From the American College of Physicians.
   Ann Intern Med. 2026 May 12. doi: 10.7326/ANNALS-25-04194.
   PubMed         Abstract available
   
   

   
   BMJ

2. SUMMERS C, Cook T, Suntharalingam G, Fong K, et al
   Covid Inquiry module 3 reveals critical gaps in UK health system resilience.
   BMJ. 2026;393:s846.
   PubMed        
   
   

   
   Br J Anaesth

3. FRASER S, Syratt T, Bridson JD, Gilbert-Kawai N, et al
   Refusal of blood transfusion based on donor COVID-19 vaccination status: an emerging postpandemic challenge for perioperative care.
   Br J Anaesth. 2026 May 13:S0007-0912(26)00279-5. doi: 10.1016/j.bja.2026.
   PubMed        
   
   

   
   Clin Infect Dis

4. PEREZ MA, Patel KA, Rasmy L, Yoshida H, et al
   Changes in Epidemiology of Candidemia in the United States with a Focus on Candida auris.
   Clin Infect Dis. 2026 May 11:ciag312. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Infect Control Hosp Epidemiol

5. MENG L, Bell JM, Barbre K, Guthrie S, et al
   Using a longitudinal k-means clustering method to explore nursing home factors associated with SARS-CoV-2 infection peak and resilience to a COVID-19 surge.
   Infect Control Hosp Epidemiol. 2026 May 14:1-7. doi: 10.1017/ice.2026.10406.
   PubMed         Abstract available
   
   

   
   Int J Infect Dis

6. KIM S, Chun BC
   Heterogeneous Rebound Patterns of Foodborne Diseases after COVID-19 Non-Pharmaceutical Interventions, South Korea, 2005-2024.
   Int J Infect Dis. 2026 May 13:108782. doi: 10.1016/j.ijid.2026.108782.
   PubMed         Abstract available
   
   
7. WENG TP, Li MC, Tsai HP, Chen CJ, et al
   Viral Rebound and Clinical Outcomes in Hospitalized Patients with COVID-19.
   Int J Infect Dis. 2026 May 13:108796. doi: 10.1016/j.ijid.2026.108796.
   PubMed         Abstract available
   
   
8. SHI R, Li Y, Liu L, Wang Y, et al
   Molecular epidemiology and genomic characterization of post-pandemic macrolide-resistant Mycoplasma pneumoniae in hospitalized children.
   Int J Infect Dis. 2026 May 13:108780. doi: 10.1016/j.ijid.2026.108780.
   PubMed         Abstract available
   
   
9. MARTINEZ-DIAZ I, Nunez-Delgado S, Ortiz-Perez JT, Morales A, et al
   Increased circulating ACE2 and GAS6 are independent predictors of COVID-19 severity.
   Int J Infect Dis. 2026 May 12:108775. doi: 10.1016/j.ijid.2026.108775.
   PubMed         Abstract available
   
   
10. HEYMER EJ, Campbell H, Clark SA, Lucidarme J, et al
    Lower incidence and higher case fatality rates associated with invasive meningococcal disease during COVID-19 pandemic restrictions (March 2020 to July 2021) in England.
    Int J Infect Dis. 2026 May 10:108770. doi: 10.1016/j.ijid.2026.108770.
    PubMed         Abstract available
    
    
11. NIAMSANIT S, Sitthikarnkha P, Techasatian L, Saengnipanthkul S, et al
    Incidence Trends, Outcomes, and Factors Associated with Mortality in Multisystem Inflammatory Syndrome in Children: A Nationwide Study in Thailand during 2021-2023.
    Int J Infect Dis. 2026 May 6:108766. doi: 10.1016/j.ijid.2026.108766.
    PubMed         Abstract available
    
    

    
    J Med Virol

12. YAVUZ HC, Boysan SN, Tuna MM
    FIB-4 Index and APRI Score Predict Short- and Long-Term Mortality in Hospitalized COVID-19 Patients: A 4-Year Follow-Up Study.
    J Med Virol. 2026;98:e70964.
    PubMed         Abstract available
    
    
13. KIM DS, Kim U, Woo HM, Lee H, et al
    Broad Neutralizing Activity of Monoclonal Antibodies Against the Omicron Variants Isolated From Patients With Early Severe Acute Respiratory Syndrome Coronavirus-2.
    J Med Virol. 2026;98:e70969.
    PubMed         Abstract available
    
    

    
    J Virol

14. MCCABE M, Groves HE, Getty E, Campbell E, et al
    Age-dependent expression and antiviral activity of interferon epsilon in respiratory epithelium.
    J Virol. 2026 May 12:e0057825. doi: 10.1128/jvi.00578.
    PubMed         Abstract available
    
    
15. LI P, Zheng Y-M, Liu S-L
    Altered infectivity, cell-cell fusion, and immune evasion of SARS-CoV-2 BA.3.2 and LP.8.1 variants.
    J Virol. 2026 May 12:e0001626. doi: 10.1128/jvi.00016.
    PubMed         Abstract available
    
    

    
    Lancet Infect Dis

16. HANSEN CH, Soborg B, Rasmussen M, Moustsen-Helms IR, et al
    Effectiveness of the BNT162b2 LP.8.1-adapted SARS-CoV-2 vaccine against COVID-19-associated hospitalisation and death: a Danish nationwide cohort study.
    Lancet Infect Dis. 2026 May 13:S1473-3099(26)00236.
    PubMed        
    
    

    
    N Engl J Med

17. HAYDEN FG, Shinkai M, Clark TW, Luetkemeyer AF, et al
    Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts.
    N Engl J Med. 2026;394:1905-1915.
    PubMed         Abstract available
    
    

    
    Nature

18. DOLGIN E
    At last, a pill that can prevent COVID after exposure to infected people.
    Nature. 2026 May 13. doi: 10.1038/d41586-026-01546.
    PubMed        
    
    

    
    Science

19. LESSLER J, Christensen A
    From wastewater analysis to public health action.
    Science. 2026;392:692.
    PubMed         Abstract available
    
    
20. HILL DT, Schulman R, Caldas IV, Dunham C, et al
    Genetic variability of SARS-CoV-2 in wastewater and associations with community transmission.
    Science. 2026;392:735-741.
    PubMed         Abstract available